电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

HLA-DPB1 抗体 (AA 30-225)

HLA-DPB1 适用: 人 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
产品编号 ABIN7155585
发货至: 中国
  • 抗原 See all HLA-DPB1 抗体
    HLA-DPB1 (Major Histocompatibility Complex, Class II, DP beta 1 (HLA-DPB1))
    抗原表位
    • 16
    • 7
    • 6
    • 6
    • 6
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    AA 30-225
    适用
    • 63
    • 21
    • 3
    • 2
    • 2
    宿主
    • 50
    • 13
    克隆类型
    • 45
    • 18
    多克隆
    标记
    • 34
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This HLA-DPB1 antibody is un-conjugated
    应用范围
    • 48
    • 28
    • 26
    • 21
    • 16
    • 13
    • 13
    • 11
    • 4
    • 4
    • 3
    • 2
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
    交叉反应
    纯化方法
    >95%, Protein G purified
    免疫原
    Recombinant Human HLA class II histocompatibility antigen, DP beta 1 chain protein (30-225AA)
    亚型
    IgG
    Top Product
    Discover our top product HLA-DPB1 Primary Antibody
  • 应用备注
    Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
    限制
    仅限研究用
  • 状态
    Liquid
    缓冲液
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    储存液
    ProClin
    注意事项
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    储存条件
    -20 °C,-80 °C
    储存方法
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 抗原
    HLA-DPB1 (Major Histocompatibility Complex, Class II, DP beta 1 (HLA-DPB1))
    别名
    HLA-DPB1 (HLA-DPB1 产品)
    别名
    PATR-DPB1 antibody, B-LB antibody, B-LB2 antibody, B-LB21 antibody, BLB1 antibody, GSP-BLB1 antibody, DPB1 antibody, HLA-DP antibody, HLA-DP1B antibody, HLA-DPB antibody, major histocompatibility complex, class II, DP beta 1 antibody, Major histocompatibility complex class II beta chain BLB1 antibody, PATR-DPB1 antibody, BLB1 antibody, HLA-DPB1 antibody
    背景

    Background: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.

    Aliases: beta1 domain MHC class II HLA DPB antibody, class II histocompatibility antigen, DP(W4) beta chain antibody, class II HLA beta chain antibody, DP beta 1 chain antibody, DP(W4) beta chain antibody, DPB1 antibody, DPB1_HUMAN antibody, HLA class II histocompatibility antigen antibody, HLA class II histocompatibility antigen, DP beta 1 chain antibody, HLA class II histocompatibility antigen, DP(W4) beta chain antibody, HLA DP14-beta chain antibody, HLA-DP antibody, HLA-DP histocompatibility type, beta-1 subunit antibody, HLA-DP1B antibody, HLA-DPB antibody, HLA-DPB1 antibody, major histocompatibility complex class II antigen beta chain antibody, major histocompatibility complex, class II, DP beta 1 antibody, MHC class II antigen beta chain antibody, MHC class II antigen DP beta 1 chain antibody, MHC class II antigen DPB1 antibody, MHC class II antigen DPbeta1 antibody, MHC class II HLA-DP-beta-1 antibody, MHC class II HLA-DRB1 antibody, MHC HLA DPB1 antibody

    UniProt
    P04440
    途径
    TCR Signaling, Cancer Immune Checkpoints
You are here: